314140 — RP Bio lnc Income Statement
0.000.00%
- KR₩67bn
- KR₩84bn
- KR₩151bn
- 65
- 61
- 39
- 58
Annual income statement for RP Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69,855 | 97,923 | 114,964 | 138,109 | 151,046 |
Cost of Revenue | |||||
Gross Profit | 10,782 | 12,639 | 12,938 | 17,779 | 15,569 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 67,085 | 92,944 | 110,058 | 130,785 | 144,424 |
Operating Profit | 2,770 | 4,978 | 4,906 | 7,324 | 6,623 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,669 | 4,209 | 4,291 | 5,669 | 5,658 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,864 | 4,616 | 3,813 | 4,316 | 5,437 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,864 | 4,616 | 3,813 | 4,316 | 5,437 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,864 | 4,616 | 3,813 | 4,469 | 5,437 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 366 | 523 | 598 | 841 | 647 |
Dividends per Share |